56% vs 39%: p < 0, 0001 og ALT normalisering på 70% vs 62%) mellem henholdsvis telbuvidin og lamivudin.
56% vs 39%; p < 0.0001 and ALT normalisation of 70% vs 62%) demonstrated a widening difference at week 104 between telbivudine and lamivudine, respectively.